| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Miller Joseph M50 | Chief Financial Officer | Sell | 34,811 | $5.60 | $194,941.60 | -6.6% | -4.5% | +48.4% | |
| Mar 6, 2024 | Donley Matthew Maxwell54 | EVP, Ops &Strategy | Sell | 40,665 | $5.51 | $224,064.15 | -6.5% | -4.5% | +48.4% | |
| Mar 6, 2024 | Habig Scott Michael46 | Chief Commercial Officer | Sell | 17,777 | $5.60 | $99,551.20 | -3.6% | -4.5% | +48.4% | |
| Mar 6, 2024 | Robertson Stephen P. | EVP, General Counsel | Sell | 57,745 | $5.60 | $323,372.00 | -11.5% | -4.5% | +48.4% | |
| Feb 27, 2024 | Knappertz Volker | EVP, Research And Development | Sell | 4,930 | $6.10 | $30,073.00 | -1.5% | -12.1% | +32.1% | |
| Feb 20, 2024 | Knappertz Volker | EVP, Research And Development | Sell | 25,146 | $5.48 | $137,800.08 | -7.2% | +3.4% | +40.8% | |
| Feb 20, 2024 | Habig Scott Michael46 | Chief Commercial Officer | Sell | 15,867 | $5.48 | $86,951.16 | -3.1% | +3.4% | +40.8% | |
| May 23, 2023 | Billen Daniel | Director | Sale+OE | 4,650 | $11.26 | $52,359.00 | -12.2% | -15.6% | -51.1% | |
| May 23, 2023 | Jayne David R.W. | Director | Sale+OE | 8,733 | $11.26 | $98,333.58 | -15.0% | -15.6% | -51.1% | |
| May 23, 2023 | MacKay-Dunn R. Hector47 | Director | Sale+OE | 4,818 | $11.26 | $54,250.68 | -16.6% | -15.6% | -51.1% |